Results 131 to 140 of about 27,582 (263)
Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review
Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1399-1417, June 2026.Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes +6 more
wiley +1 more source
Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1374-1382, June 2026.Abstract Background Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as tremors, rigidity, and bradykinesia. Structural brain changes, including atrophy in the midbrain, basal ganglia, and cortical regions such as the frontal and temporal lobes, are observed in advanced stages.
Suraiya Mangra +5 more
wiley +1 more source
Medication Knowledge of Patients with Parkinson's Disease: Strengths and Gaps
Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1427-1434, June 2026.Abstract Background Effective drug treatment of motor and non‐motor symptoms in Parkinson's disease (PD) often requires the administration of several anti‐Parkinson drugs in complex treatment regimens. The successful autonomous application of drugs places high demands on therapy adherence, which in turn relies on sufficient medication knowledge ...
Stephan Greten +9 more
wiley +1 more source
, 1897 ÜBER CHOREA MINOR Über Chorea minor ([1]) Title page ([1]) Dedication ([3]) Definition. ([5]) Ätiologie. (6) Pathologische Anatomie. (14) Symptomatologie und Verlauf. (17) Diagnose. (25) Therapie. (25)
Mansfeld, Alfred
core
Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1383-1398, June 2026.ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan +4 more
wiley +1 more source
Patient‐Reported Communication Decline Following Deep Brain Stimulation in Parkinson's Disease
Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1522-1527, June 2026.Abstract Background Objective decline in communication abilities following Deep Brain Stimulation (DBS) in People with Parkinson's disease (PwP) is common; however, patient perspectives remain under‐investigated. Objectives This study examined subjective change in communicative efficacy using the Communicative Participation Item Bank (CPIB) in PwP ...
Stephanie M. Simone +2 more
wiley +1 more source
Increased striatal glucose consumption in Sydenham's chorea
, 1993 Positron emission tomography and 18F‐fluorodeoxyglucose were used to measure the regional cerebral glucose consumption in a 15‐year‐old choreatic girl with classical Sydenham's chorea shortly after the onset of hyperkinetic movements and 5 months later ...
Poremba M +9 more
core +1 more source
Epileptic Disorders, Volume 28, Issue 3, Page 920-924, June 2026.
Roberta Cutellè +8 more
wiley +1 more source
Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1513-1517, June 2026.Abstract Background The Huntington's Disease Behavioral Questionnaire (HD‐BQ) captures behavioral symptoms arising from cognitive, psychiatric, and functional domains. Recognizing the high prevalence of anosognosia in HD, the HD‐BQ incorporates patient‐ and companion‐reported versions.
Siena Rigatuso +5 more
wiley +1 more source
Chorea in primary antiphospholipid syndrome
, 1996 A 12-year-old girl with chorea, thrombocytopenia and false positive VDRL had negative serological tests for SLE, but high titre of antiocardiolipine antibodies.
C. Masala +5 more
core +1 more source